HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND RITUXIMAB (R-HDS) IN HIV+ PATIENTS WITH NON-HODGKIN LYMPHOMA (NHL) REFRACTORY OR RELAPSED AFTER 1st LINE TREATMENT.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2013
At a glance
- Drugs Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Filgrastim; Melphalan; Mitoxantrone; Rituximab
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 18 Aug 2011 New trial record